Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2–Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial
The results suggested that eribulin + HP is an option for first-line treatment of locally advanced/metastatic HER2+ BC.
Authors
- Natsuko Mori
- Masato Takahashi (ORCID: https://orcid.org/0000-0002-6641-9598)
- Junji Tsurutani (ORCID: https://orcid.org/0000-0002-6260-6943)
- Hiroki Hasegawa (ORCID: https://orcid.org/0000-0002-0709-7680)
- Akiyo Yoshimura (ORCID: https://orcid.org/0000-0002-5274-9158)
- Shigehira Saji (ORCID: https://orcid.org/0000-0002-6732-8030)
- Toshinari Yamashita (ORCID: https://orcid.org/0000-0002-6479-1660)
- Toshimi Takano (ORCID: https://orcid.org/0000-0002-8417-5291)
- Yohei Uchida
- Michiko Tsuneizumi
- Tsutomu Iwasa (ORCID: https://orcid.org/0000-0001-5996-0602)
- Yoichi Naito (ORCID: https://orcid.org/0000-0002-8490-9064)
- Norikazu Masuda (ORCID: https://orcid.org/0000-0002-7302-0278)
- Tsuguo Iwatani (ORCID: https://orcid.org/0000-0001-7162-1515)
- Masahiro Kitada (ORCID: https://orcid.org/0000-0002-9741-0510)
- Toru Higuchi (ORCID: https://orcid.org/0000-0001-6325-6124)
- Hiroshi Tada (ORCID: https://orcid.org/0000-0003-2670-8982)
- Satoshi Morita (ORCID: https://orcid.org/0000-0002-4344-3317)
- Kazuhiro Araki (ORCID: https://orcid.org/0000-0001-7623-7715)
- Kei Koizumi
Institutions
- SHOWA Medical University (JP)
- Fukushima Medical University (JP)
- Asahikawa Medical University (JP)
- Kyoto University (JP)
- Kanagawa Prefectural Hospital Organization (JP)
- Hamamatsu University School of Medicine (JP)
- Tohoku University Hospital (JP)
- Kindai University Hospital (JP)
- Okayama University Hospital (JP)
- Seirei Hamamatsu General Hospital (JP)
- Aichi Cancer Center (JP)
- Shizuoka General Hospital (JP)
- The Cancer Institute Hospital (JP)
- Hokkaido University Hospital (JP)
- National Cancer Center Hospital East (JP)
- Saitama Red Cross Hospital (JP)
- Kanagawa Cancer Center
- National Hospital Organization Saitama Hospital
- Eisai (Japan) (JP)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1200/jco-24-01888
- Citations
- 8
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 8.36